Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if KYTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
23 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
121 filers reported a long position in KYTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GordonMD Global Investments LP | $37.8M | 4.2M | Unchanged |
| GILEAD SCIENCES, INC. | $36.8M | 4.1M | Unchanged |
| BlackRock, Inc. | $27.9M | 3.1M | +257.4% |
| Bain Capital Life Sciences Investors, LLC | $25.7M | 2.9M | -7.2% |
| AIGH Capital Management LLC | $24.9M | 2.8M | +39.8% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $17.8M | 2M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.9M | 1.9M | +6.4% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $10.6M | 1.2M | -23.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $9.4M | 1M | +147.6% |
| Insight Holdings Group, LLC | $8.8M | 989.1K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.